Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01157676 | Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial | completed | N/A | 350 | University of MiamiOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT04603612 | The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor. | completed | N/A | 254 | Mansoura UniversityOTHER | 1 | Oct 27, 2020 | clinicaltrials |
| NCT00341861 | Interdisciplinary Case-Control Study of Bladder Cancer in Spain | completed | — | 2,925 | National Cancer Institute (NCI)NIH | 1 | Oct 22, 2020 | clinicaltrials |
| NCT00003930 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | completed | Phase 1 / Phase 2 | 84 | Radiation Therapy Oncology GroupNETWORK | 2 | Oct 20, 2020 | clinicaltrials |
| NCT03639090 | Mass Spectrometry in Single Bladder Cancer Cells | completed | — | 2 | University of OklahomaOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT00478361 | Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function | completed | Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 9, 2020 | clinicaltrials |
| NCT03138967 | Investigation of Sugammadex in Outpatient Urological Procedures | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT02555163 | Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)(HoLERBT) | completed | N/A | 100 | Mansoura UniversityOTHER | 1 | Sep 18, 2020 | clinicaltrials |
| NCT00749892 | Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer | completed | Phase 2 | 34 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 10, 2020 | clinicaltrials |
| NCT00088946 | Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer | completed | Phase 2 | 17 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT02092948 | Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer | completed | Phase 1 | 8 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT03672240 | Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment(NMIBC) | completed | Phase 1 / Phase 2 | 6 | Asieris Pharmaceutical Technologies Co., Ltd.INDUSTRY | 1 | Jul 20, 2020 | clinicaltrials |
| NCT00342875 | The New England Bladder Cancer Study | completed | — | 2,681 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2020 | clinicaltrials |
| NCT03147599 | Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders | completed | Phase 4 | 110 | Mansoura UniversityOTHER | 1 | Jun 30, 2020 | clinicaltrials |
| NCT02662166 | MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer(MIB) | completed | N/A | 50 | Turku University HospitalOTHER_GOV | 1 | Jun 17, 2020 | clinicaltrials |
| NCT04229862 | Effect of Head Elevation on LMA Insertion | completed | N/A | 110 | Asan Medical CenterOTHER | 1 | May 29, 2020 | clinicaltrials |
| NCT00462488 | Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ | completed | Phase 2 | 46 | Sesen Bio, Inc.INDUSTRY | 2 | May 12, 2020 | clinicaltrials |
| NCT00776178 | Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health | completed | — | 68 | National Cancer Institute (NCI)NIH | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03534492 | Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)(NEODURVARIB) | completed | Phase 2 | 29 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Apr 6, 2020 | clinicaltrials |
| NCT01273987 | Neobladder Posterior Wall Suspended With Round Ligament of Uterus | completed | N/A | 76 | Zhiwen ChenOTHER | 1 | Mar 31, 2020 | clinicaltrials |
| NCT04317261 | Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria | completed | N/A | 181 | Mansoura UniversityOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT04310813 | Microscopic-spectroscopic Examination for Urothelial Tissue Characterization(MSUT) | completed | — | 114 | Careggi HospitalOTHER | 0 | Mar 18, 2020 | clinicaltrials |
| NCT01076387 | Randomized Trial Comparing Robotic and Open Radical Cystectomy | completed | Phase 3 | 124 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 16, 2020 | clinicaltrials |
| NCT02028442 | Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients(EVOLVE) | completed | Phase 1 / Phase 2 | 61 | Akamis BioINDUSTRY | 2 | Mar 12, 2020 | clinicaltrials |
| NCT02053220 | Mechanism of Action Trial of ColoAd1(MOA) | completed | Phase 1 | 17 | Akamis BioINDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT02720367 | Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer | completed | Phase 1 | 12 | Taris Biomedical LLCINDUSTRY | 1 | Mar 10, 2020 | clinicaltrials |
| NCT00848627 | Screening for Bladder Cancer | completed | — | 197 | Baylor College of MedicineOTHER | 2 | Feb 25, 2020 | clinicaltrials |
| NCT04212403 | Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)(Prophylaxis001) | completed | N/A | 1,350 | Jessa HospitalOTHER | 1 | Feb 24, 2020 | clinicaltrials |
| NCT04110483 | Thulium Fiber Laser En-bloc Resection vs Conventional Transurethral Resection of Non-muscle-invasive Bladder Cancer | completed | N/A | 130 | I.M. Sechenov First Moscow State Medical UniversityOTHER | 1 | Feb 18, 2020 | clinicaltrials |
| NCT03125460 | Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer | completed | — | 424 | CepheidINDUSTRY | 3 | Feb 7, 2020 | clinicaltrials |
| NCT01846520 | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | completed | N/A | 200 | City of Hope Medical CenterOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT03159585 | To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors | completed | Phase 1 | 6 | Zhujiang HospitalOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT00445601 | S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer | completed | Phase 3 | 406 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00978250 | A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) | completed | Phase 2 | 95 | National Cancer Institute (NCI)NIH | 1 | Dec 27, 2019 | clinicaltrials |
| NCT00722553 | Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | completed | Phase 2 | 30 | Acrotech Biopharma Inc.INDUSTRY | 6 | Dec 17, 2019 | clinicaltrials |
| NCT02178241 | Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 2 | Dec 16, 2019 | clinicaltrials |
| NCT04194112 | Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study | completed | N/A | 198 | Mansoura UniversityOTHER | 0 | Dec 12, 2019 | clinicaltrials |
| NCT03715660 | Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study | completed | N/A | 198 | Mansoura UniversityOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT04162093 | New Technique for Uretero-ileal Anastomosis for Patient With Bladder Cancer Who Are Suitable for Orthotopic Neobladder | completed | N/A | 45 | Ain Shams UniversityOTHER | 0 | Nov 15, 2019 | clinicaltrials |
| NCT01478685 | A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 169 | CelgeneINDUSTRY | 4 | Nov 12, 2019 | clinicaltrials |
| NCT00005858 | LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer | completed | Phase 1 | 25 | University of Maryland, BaltimoreOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT03156244 | Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients | completed | — | 80 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT03591367 | The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation | completed | N/A | 115 | Mansoura UniversityOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT01655745 | Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer | completed | N/A | 22 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT02665039 | A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function(VINGEM) | completed | Phase 2 | 62 | Dr Anders UllénOTHER | 2 | Oct 8, 2019 | clinicaltrials |
| NCT01589094 | Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT00794950 | Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma(Sutent) | completed | Phase 2 | 43 | University of MichiganOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT02648178 | Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers | completed | N/A | 19 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Sep 19, 2019 | clinicaltrials |
| NCT02141490 | Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 6, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Nov 3, 2020source: clinicaltrials